~~<i id='001373EAB7'><strike id='001373EAB7'><tt id='001373EAB7'><pre id='001373EAB7'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

author：focus 2025-10-01 18:35:22 - browse：7

WASHINGTON — Back in 1980, when the Food and Drug Administration approved the use of lead acetate in hair dyes, little was known about the way skin absorbs toxic chemicals.

The skin — and the scalp in particular — were considered tough barriers to break, and many public health officials believed that even if small amounts of lead got through, or were inhaled, it couldn’t really hurt anyone.

But in science, 37 years is an eon. So a coalition of environmental groups, academics, and consumer advocates is pushing FDA to take lead acetate off the market. It is now permitted as a color additive.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Medicare Advantage's lean provider networks lead CMS complaints

hotspot

explore

Wikipedia

explore

entertainment

hotspot

AdobeThefederalgovernmentinappropriatelyloweredthe2024MedicareAdvantagestarratingsofSCANHealthPlan,w

WSS

Illumina board agrees to spin off Grail, as divestment plans proceed

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Readout Newsletter: Amylyx, Aurinia, and IQVIA

UnitedHealth CEO's Medicaid comments send insurer stocks diving

FTC loses bid to block Novant's North Carolina hospital merger

'Little Tech' descents on D.C., wanting a say in how AI is regulated

knowledge

knowledge

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Ebola vaccine can save some who are already sick, per new study

Duchenne breakthrough therapy leaves behind pioneering families

FTC loses bid to block Novant's North Carolina hospital merger

As demand for Covid shots wanes, Moderna seeks its next success

Study gives hint on South Asians’ higher risk of cardiovascular disease

Tori Bowie and the unacceptable rates of Black maternal death

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Anesthesiologist group: stop taking Ozempic before surgery

Eli Lilly reports tirzepatide MASH success during Q4 earnings

explore

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Elevance PBM president out as customers face prescription chaos

Anthony Fauci pushes back on GOP claims during Covid hearing

STAT Boddities: What happens to the brain when we get scared?

A new initiative will help leaders fight the next pandemic

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Wikipedia

explore

entertainment

hotspot